semaglutide anorexia Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders Semaglutide effects on energy balance

doi: 10.1074/jbc.M710349200 21 FiorentiniCSavoiaPSavoldiDBarbonAMissaleC

Following the phase 2 results published in 2023, Eli Lilly has progressed retatrutide into phase 3 clinical development

CCL2/Monocyte chemoattractant protein 1 and parathyroid hormone action on bone

By reducing the amount of medication that enters the bloodstream, inserts also enhance safety [359]

Similarly, a national cohort of more than 16,000 patients with MASLD and diabetes showed that GLP-1 RA therapy was linked to lower rates of cirrhosis progression, hepatic decompensation, and HCC, but only when initiated prior to the development of cirrhosis

Alternative methods for modulating glutamatergic neurotransmission are needed in this veteran population